Ruth Lovering
University of London
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ruth Lovering.
Immunology Today | 1993
Christine Kinnon; Steve Hinshelwood; Roland J. Levinsky; Ruth Lovering
The btk gene has recently been identified as the causative gene in X-linked agammaglobulinemia (XLA). This has opened up many new possibilities for the treatment of this B-cell immunodeficiency. Christine Kinnon and colleagues review the high degree of sequence of homology of btk to the non-receptor tyrosine kinases and speculate on putative roles for this gene in B-cell development.
Journal of Immunological Methods | 1993
Lesley A. Alterman; Mahesh de Alwis; Sally Genet; Ruth Lovering; Helen Middleton-Price; Gareth J. Morgan; Alison Jones; Sue Malcolm; Roland J. Levinsky; Christine Kinnon
We report the development of a relatively quick and simple method for the assessment of X inactivation status for carrier determination in families affected by X-linked agammaglobulinemia (XLA). This method utilises an immunomagnetic separation technique for B cell purification and a polymerase chain reaction (PCR) based assay for the determination of methylation status at the androgen receptor (AR) gene locus to assess whether X inactivation is random or non-random at this locus. We report the results we have obtained using this assay to investigate females known to be carriers of various X-linked immunodeficiency disorders. In addition, we investigated four females from different families affected by XLA, two of whom were of unknown carrier status, and we discuss the results obtained with this and other X-inactivation assays. A similar assay has recently been described by Allen et al. (1992) and applied to members of one family affected by XLA.
Human Genetics | 1994
M. H. Parkar; Ruth Lovering; Roland J. Levinsky; Christine Kinnon
The dinucleotide repeat sequences at the DXS454 and DXS458 loci have been mapped genetically to Xq22, to the interval between DXS3 and DXS17. We have now mapped them with respect to XLA and five other loci, to within the DXS3 to XLA interval. The more precise localisation of these polymorphic loci will be useful for the fine-mapping of disease loci on the long arm of the X chromosome and enable these probes to be used for prenatal diagnosis and carrier status determination in families with XLA.
Human Genetics | 1994
Angela K. Sweatman; Linda D. Bradley; Ruth Lovering; Marie-Anne J. O'Reilly; Roland J. Levinsky; Christine Kinnon
We have produced physical maps of the proximal part of Xq22, containing the Brutons tyrosine kinase (BTK) and α-galactosidase A (GLA) gene loci, using long range physical mapping techniques and yeast artificial chromosomes (YACs). These maps reveal five previously unidentified CpG islands which could indicate the presence of other genes in this region.
Journal of Experimental Medicine | 1995
Giles O. Cory; Ruth Lovering; S. Hinshelwood; L. Maccarthy-Morrogh; Roland J. Levinsky; Christine Kinnon
Journal of Immunology | 1996
Giles O. Cory; L. Maccarthy-Morrogh; S. Banin; I. Gout; Paul M. Brickell; Roland J. Levinsky; Christine Kinnon; Ruth Lovering
Human Molecular Genetics | 1994
Linda D. Bradley; Angela K. Sweatman; Ruth Lovering; Alison Jones; Gareth J. Morgan; Roland J. Levinsky; Christine Kinnon
Leukemia | 1994
Fay Katz; Ruth Lovering; Linda D. Bradley; K. P. Rigley; D. Brown; F. Cotter; J. M. Chessells; Roland J. Levinsky; Christine Kinnon
Human Molecular Genetics | 1993
Ruth Lovering; Helen Middleton-Price; Marie-Anne J. O'Reilly; Sally Genet; M. H. Parkar; Angela K. Sweatman; Linda D. Bradley; Lesley A. Alterman; Sue Malcolm; Gareth J. Morgan; Roland J. Levinsky; Christine Kinnon
Immunodeficiency , 5 (3) pp. 179-185. (1995) | 1995
Christine Kinnon; Ruth Lovering; O'Reilly Ma; Angela K. Sweatman; Linda D. Bradley; M. H. Parkar; Lesley A. Alterman; Roland J. Levinsky